• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.03% Nasdaq Down1.13%

    Ultragenyx Pharmaceutical Inc. (RARE)

    90.00 Down 10.00(10.00%) 11:51AM EDT - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.2
    Mean Recommendation (last week):2.2

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:107.13
    Median Target:119.50
    High Target:125.00
    Low Target:79.00
    No. of Brokers:8

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 1, 2015Raymond JamesInitiated Outperform
    Jul 27, 2015Morgan StanleyDowngradeOverweightEqual-Weight
    Jul 9, 2015JMP SecuritiesInitiated Mkt Outperform
    Mar 31, 2015MLV & CoInitiated Buy
    Feb 25, 2014Canaccord GenuityInitiated Buy
    Aug 27, 2007BB&T Capital MktsDowngradeBuyHold
    Aug 17, 2007KeyBanc Capital Mkts / McDonaldDowngradeBuyHold
    Feb 16, 2007Sun Trust Rbsn HumphreyUpgradeNeutralBuy
    Feb 15, 2007RBC Capital MktsDowngradeOutperformSector Perform
    Jan 18, 2007JP MorganDowngradeOverweightNeutral

    More Upgrades & Downgrades for RARE

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000

    Data provided by Thomson/First Call

    Currency in USD.